Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 317 results for "clinigene"

New Managed Access programme for isavuconazole
CPhI.cn

CLINIGEN : Idis Starts Managed Access Programme For Horizon's ...

LONDON (Alliance News) - Pharmaceutical services company Clinigen Group PLC on Wednesday said its Idis Managed Access arm and Horizon Pharma PLC have started a managed access programme in Europe for Horizon's Ravicti Oral Liquid. Ravicti has ... 4 Traders, 8 hours ago
New MA program with Horizon Pharma MoneyAM, 9 hours ago
[x]  

8 images for clinigene

Mideast Time, 1 day ago
Octafinance, 6 days ago
proactiveinvestors.co.uk, 5 hours ago
Proactive Investors.co.uk, 2 weeks ago
DirectorsTalk, 2 weeks ago
Yahoo! Finance UK and Ireland, 3 weeks ago
Octafinance, 1 month ago
Proactive Investors.co.uk, 1 month ago

BRIEF-Clinigen, Cumberland enter into U.S. commercialisation deal for ethyol

May 10 Clinigen Group Plc * Co and Cumberland Pharmaceuticals enter into exclusive u.s. Commercialisation agreement for oncology support drug ethyol Source text for Eikon: Further company coverage: Our top photos from the last
 Reuters UK1 month ago Cumberland Pharmaceuticals and Clinigen Group enter into exclusive U.S. commercialization agreement for oncology..  ADVFN India1 month ago Clinigen strikes US drug agreement  Insider Media Limited1 month ago Clinigen to commercialise Ethyol in US  Stock Market Wire1 month ago
[x]  
Yahoo! Finance UK and Ireland

Clinigen Group plc Holding(s) in Company

 ADVFN UK2 weeks ago Are Sirius Minerals plc, Next Fifteen Communications Group plc and Clinigen Group plc the 3 hottest small-cap stocks around?  Yahoo! Finance UK and Ireland4 weeks ago
[x]  

CLINIGEN : Inks Deal With Cumberland Pharmaceuticals For Ethyol

LONDON (Alliance News) - Clinigen Group PLC said Tuesday it has signed an exclusive deal with NASDAQ-listed Cumberland Pharmaceuticals Inc to commercialise cancer support drug Ethyol in the US. This is the first product Clinigen has licensed to ...
 4 Traders1 month ago Clinigen Inks Deal With Cumberland Pharmaceuticals For Ethyol  London Stock Exchange1 month ago
Proactive Investors.co.uk

Clinigen to manage access for Horizon drug

Horizon's Ravicti oral liquid will be available to eligible patients with UCDs in selected European countries prior to commercial launch Clinigen Group PLC's (LON:CLIN) managed access business Idis has teamed up with Horizon Pharma PLC (LON:HZD) to ...
 Proactive Investors.co.uk5 hours ago Clinigen agrees managed accessed deal for Horizon's UCD drug  Proactive Investors.co.uk6 hours ago Clinigen sets up managed access in Europe for fungal drug  Proactive Investors.co.uk2 weeks ago
Mideast Time

Numis Securities Ltd Reaffirms Buy Rating for Clinigen Group PLC (CLIN)

Numis Securities Ltd restated their buy rating on shares of Clinigen Group PLC (LON:CLIN) in a research report released on Friday morning. Clinigen Group PLC (LON:CLIN) opened at 580.25 on Friday. The stock's market cap is GBX 647.55 million.
 Ticker Report7 hours ago Numis Securities Ltd Reiterates Buy Rating for Clinigen Group PLC (CLIN)  Mideast Time1 day ago Clinigen Group PLC (CLIN) Given Buy Rating at Numis Securities Ltd  SleekMoney2 days ago Clinigen Group PLC (CLIN) Stock Rating Reaffirmed by Peel Hunt  SleekMoney2 days ago
[x]  

Clinigen teams up with Horizon on RAVICTI

Josh White (ShareCast News) - Clinigen Group was celebrating on Wednesday, as its Idis Managed Access division and Nasdaq-traded Horizon Pharma initiated a Managed Access Programme in Europe for Horizon's RAVICTI oral liquid. The AIM-traded firm ...
 BullBearings8 hours ago Clinigen  London South East8 hours ago

Market Movers - Top risers and fallers between 13:00 and 14:00

Overall Market Clinigen Group 532.50 +0.71% Ceres Power Holdings 8.88 +0.57% Millennium & Copthorne Hotels 427.50 +0.31% Worldwide Healthcare Trust 1770.50 ...
 MoneyAM1 week ago

Clinigen supply agreement with Galen

StockMarketWire.com - Clinigen Group's Idis Global Access division has signed an exclusive supply agreement with Galen, a privately owned pharmaceutical sales and marketing company. Under the terms of the supply agreement, Idis GA will provide ...
 Stock Market Wire2 weeks ago
[x]  
DirectorsTalk

Peter George, chief executive of clinical trial services firm Clinigen Group PLC (LON:CLIN)

says the company has made a really big effort to extend our global footprint in 2016, and now has a complete global reach. As part of this strategy, the company has teamed up with Swiss group Basilea to start a managed access programme throughout ...
 DirectorsTalk2 weeks ago Clinigen now has a complete global reach, says chief  Proactive Investors.co.uk2 weeks ago Information Services Corp chief expects a positive and stable 2016  Proactive Investors USA1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less